Worldwide, the prevalence of<unk> -hydroxylase deficiency is 1 per 100,000 persons.<unk> -hydroxylase deficiency accounts for 5 percent of all cases of congenital adrenal hyperplasia and it is considered the second most frequent variant after 21-hydroxylase deficiency. The incidence of<unk> -hydroxylase deficiency  is 1 per 100,000 persons. Also, this disease is more common in Moroccan Jews living in Israel, occurring in approximately 20 in 100,000 newborns.<unk> -hydroxylase deficiency affects males and females equally.
11β-hydroxylase deficiency epidemiology and demographics
17 alpha-hydroxylase deficiency epidemiology and demographics
21-hydroxylase deficiency epidemiology and demographics
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
17 alpha-hydroxylase deficiency classification
21-hydroxylase deficiency laboratory findings
21-hydroxylase deficiency classification
17 alpha-hydroxylase deficiency MRI